Can Biotech Crack the AMR Dilemma? Let’s Hope So
September 5, 2025
Rocket launcher antibiotics, subscription models, and articulating value; we discuss new progress in antimicrobial therapies with Michael Murray
9 min read
False
Advertisement
Sept
A Non-Complex, Non-Toxic Method of Delivering Biologic Therapies
September 5, 2025
Meet the drug-delivery nanoparticles that self-assemble with temperature changes.
3 min read
Rotavirus Co-Inventor Removed From FDA Vaccine Committee
September 4, 2025
Paul Offit, a longtime FDA advisor and prominent figure in vaccine development, sidelined from vaccine committee amid healthcare turmoil in the US.
2 min read
Improving the Accessibility of CAR T-Cell Therapy
September 4, 2025
An international steering committee launched earlier in 2025 to improve access to CAR T-cell therapies for cancer patients. A cell therapy research specialist shares her reasons why.
9 min read
Regulators Sound Alarm on Dangers of Unapproved and Illicit GLP-1 Drugs
September 4, 2025
Increasing demand for GLP-1s sparks surge in illegal distribution
2 min read
The Multifaceted Future of Pharma – Chapter 10: The Promise of Cell and Gene Therapies
September 3, 2025
Experts explain how cell and gene therapies have disrupted the industry and what lies ahead in this sector’s future.
15 min read
Boosting Appetite for Cancer Patients
September 3, 2025
Study explores how a common psychiatric drug can help improve appetite and quality of life for people with incurable cancer and cachexia.
1 min read
This Week’s Biopharma News: Teva Wins Approval for Generic GLP-1
September 3, 2025
Our latest news roundup reports on a manufacturing platform that can produce CAR T cells within 24 hours, and stem cells for erectile dysfuntion.
4 min read
Bringing Stability to APIs Under Stress
September 2, 2025
Researchers develop new tool for evaluating API stability under various conditions.
2 min read
Formulating for Success for Prefilled Syringes
September 2, 2025
The future of biologics is high-dose, low-volume, and delivery via patient centric devices. But developing stable formulations for these high-concentration biologics comes with challenges.
6 min read
Browse by Topics
Interviews
Cell & Gene
Bioprocessing
Drug Delivery
Drug Discovery
Development & Clinical
Formulation
Facilities & Equipment
Outsourcing
Packaging
Regulation & Standards
Small Molecules
Supply Chain
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blogs